RETRACTED: Mir-124 Attenuates STAT3-Mediated TH17 Differentiation in Colitis-Driven Colon CancerShiyong Lin(Sun Yat-sen University), Jing Wang(Yuhuangding Hospital)Frontiers in OncologyDecember 17, 202010.3389/fonc.2020.570128Cited by 11SaveCiteExport RISWatch citationsRelated PapersPhase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid Tumors|Clinical Cancer Research|2014|82Antiobesity effect of L-arabinose via ameliorating insulin resistance and modulating gut microbiota in obese mice|Nutrition|2023|21